1-2 of 2
Petra Dörge
Close
Sort by
Journal Articles

The Strong Prognostic Effect of Concurrent Deletions of IKZF1 and PAX5 , CDKN2A , CDKN2B or PAR1 in the Absence of ERG Deletions (IKZF1 plus ) in Pediatric Acute Lymphoblastic Leukemia Strongly Depends on Minimal Residual Disease Burden after Induction Treatment

Elif Dagdan, PhD, Marketa Zaliova, MD PhD, Petra Dörge, Anja Möricke, Martin Zimmermann, PhD, Andrea Teigler-Schlegel, PhD, Claus R Bartram, MD, Rolf Koehler, PhD, Richard Ratei, MD, Wolf-Dieter Ludwig, MD, Julia Alten, MD, Denis Martin Schewe, MD, Christian Kratz, Prof. Dr., Richard S Houlston, Jean-Pierre Bourquin, MD PhD, Andrea Biondi, Giovanni Cazzaniga, Giuseppe Basso, MD, Geertruy te Kronnie, Marie-Laure Yaspo, Dr., Martin Schrappe, MD, Gunnar Cario, MD, Martin Stanulla, MD
Journal: Blood
Blood (2014) 124 (21): 131.
https://doi.org/10.1182/blood.V124.21.131.131
Published: 2014
Journal Articles

GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia

Philipp A. Greif, Annika Dufour, Nikola P. Konstandin, Bianka Ksienzyk, Evelyn Zellmeier, Belay Tizazu, Jutta Sturm, Tobias Benthaus, Tobias Herold, Marjan Yaghmaie, Petra Dörge, Karl-Peter Hopfner, Andreas Hauser, Alexander Graf, Stefan Krebs, Helmut Blum, Purvi M. Kakadia, Stephanie Schneider, Eva Hoster, Friederike Schneider, Martin Stanulla, Jan Braess, Maria Cristina Sauerland, Wolfgang E. Berdel, Thomas Büchner, Bernhard J. Woermann, Wolfgang Hiddemann, Karsten Spiekermann, Stefan K. Bohlander
Journal: Blood
Blood (2012) 120 (2): 395–403.
https://doi.org/10.1182/blood-2012-01-403220
Published: 2012
Includes: Supplemental data